Drug Shortage Report for TARO-SUNITINIB

Last updated on 2024-12-02 History
Report ID 238726
Drug Identification Number 02524058
Brand name TARO-SUNITINIB
Common or Proper name Sunitinib
Company Name TARO PHARMACEUTICALS INC
Market Status MARKETED
Active Ingredient(s) SUNITINIB
Strength(s) 12.5MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 3x10 Blisters
ATC code L01EX
ATC description
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-09-25
Estimated end date 2024-11-15
Actual end date 2024-11-08
Shortage status Resolved
Updated date 2024-12-02
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 130 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2024-12-02 French Compare
v7 2024-12-02 English Compare
v6 2024-11-11 French Compare
v5 2024-11-11 English Compare
v4 2024-10-17 French Compare
v3 2024-10-17 English Compare
v2 2024-09-27 French Compare
v1 2024-09-27 English Compare

Showing 1 to 8 of 8